Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07336238
Title field or adapter rule
{'original_value': 'A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:37.076146+00:00
Published At
2026-10-29T00:00:00+00:00
Record Updated At
2026-10-29
Source Retrieved At
2026-10-31T22:19:05.758047+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Anxiety", "Depression", "Hematopoietic and Lymphatic System Neoplasm", "Metastatic Malignant Solid Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-29", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07336238"
protocolSection.identificationModule.officialTitle
"A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Anxiety (protocolSection.conditionsModule.conditions)
  • Depression (protocolSection.conditionsModule.conditions)
  • Hematopoietic and Lymphatic System Neoplasm (protocolSection.conditionsModule.conditions)
  • Metastatic Malignant Solid Neoplasm (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Treatment (psilocybin therapy)'], 'description': 'Attend therapy sessions', 'name': 'Psychotherapy', 'type': 'BEHAVIORAL'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (psilocybin therapy)'], 'description': 'Given PO', 'name': 'Psilocybin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Treatment (psilocybin therapy)'], 'description': 'Ancillary studies', 'name': 'Survey Administration', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Psilocybin (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.